NCT05410210 is a NA clinical trial of Pharmaceutical care in Parkinson Disease, sponsored by Mahidol University.

Who is sponsoring NCT05410210?

NCT05410210 is sponsored by Mahidol University.

What drugs are being tested in NCT05410210?

Interventions in NCT05410210: Pharmaceutical care.

What condition does NCT05410210 study?

NCT05410210 studies Parkinson Disease.

Is NCT05410210 still recruiting?

NCT05410210 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT05410210

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Pharmaceutical Care on Drug-related Problems in Patients With Parkinson's Disease

Completed NA Last updated 10 October 2023

What this trial tests

NA trial testing Pharmaceutical care in Parkinson Disease in 80 participants. Completed in 23 January 2023.

Timeline

11 March 2022

Primary endpoint
2 December 2022

23 January 2023

Quick facts

Lead sponsor	Mahidol University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	80
Start date	11 March 2022
Primary completion	2 December 2022
Estimated completion	23 January 2023
Sites	1 location across Thailand

Drugs / interventions tested

Pharmaceutical care

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Mahidol University

Who can join

18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the impact of pharmaceutical care on the number of drug-related problems, clinical outcomes and quality of life of patients with Parkinson's disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care.
Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, et al · · 2025 · cited 1× · PMID 39945968 · DOI 10.1007/s11096-025-01883-6

Verify or expand the search:

Other trials of Pharmaceutical care

Trials testing the same drug.

NCT05104034 — Comprehensive Risk Assessment and Prevention Plan of Osteoporosis and Sarcopenia for the Elderly Participating in Commun · NA · unknown
NCT03439904 — Individualized Pharmaceutical-care in Outpatients With Cancer Pain · NA · unknown
NCT02611440 — Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients · NA · unknown

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05410210 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing